Concepedia

K. Patterson

KP

Statistics

Publications

6

Citations

181

H-Index

6

Active since

2015

Affiliations

University of Sheffield(Current)

BresMed

Merck & Co., Inc., Rahway, NJ, USA (United States)

K. Patterson is an author at University of Sheffield specializing in genome instability, medicine, and cell signaling.

ORCID

Top concepts

Publications per year

2015–2020

6

Publications

6

Human CDK18 promotes replication stress signaling and genome stability

Giancarlo Barone, Christopher J. Staples, Anil Ganesh et al. · Nucleic Acids Research · 2016 · 52 citations · Full text

, , +15

Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers

Arvind Arora, Tarek M. Abdel-Fatah, Devika Agarwal et al. · Carcinogenesis · 2015 · 34 citations · Full text

Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1–positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States

Oliver Hale, K. Patterson, Yizhen Lai et al. · Clinical Genitourinary Cancer · 2020 · 28 citations

Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy

K. Patterson, Vimalanand S. Prabhu, Ruifeng Xu et al. · European Urology Oncology · 2018 · 27 citations · Full text

Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy

K. Patterson, Lovleen Arya, Sarah Bottomley et al. · Oncotarget · 2016 · 20 citations · Full text

1–5 of 6